4’-DMA-7,8-DHF ( Eutropoflavin ) 10mg / 60 capsule
4’-DMA-7,8-DHF ( Eutropoflavin ) 10mg / 60 capsule
Currently unavailable
NovaMeds
Illustrative packaging generated with AI. Choose your strength and pack below.
Modafinil · Wakefulness-promoting agent
A wakefulness-promoting medicine used for excessive sleepiness associated with narcolepsy.
Modafinil is a wakefulness-promoting agent. In the UK and EU it is authorized for excessive sleepiness associated with narcolepsy. It is a controlled substance in some markets, including the United States.
Suitability and dosing are decided by a prescriber on the basis of the approved product information.
Modafinil promotes wakefulness. Its exact mechanism is not fully understood; it acts on the dopamine transporter and on several brain systems that regulate sleep and waking.
In the UK and the EU it is authorized only for excessive sleepiness associated with narcolepsy. In 2010 the European Medicines Agency restricted its use to this indication after reviewing the benefits and risks.1
Commonly reported side effects include:
Modafinil is a prescription-only medicine. After your request, the partner pharmacy verifies whether and how supply is possible, for example through an existing prescription or an assessment by an independent doctor where permitted.
No. In the UK and the EU it is authorized only for excessive sleepiness associated with narcolepsy. Other uses are not authorized.
Yes. Modafinil can make hormonal contraceptives less effective; the product information describes the alternative or additional methods needed.
No. Payment is arranged individually with customer service once your request has been reviewed and can proceed.